Eagles Add Jalen Hurts to IR, Sidelining QB Indefinitely After Blood Clot Discovery

**Jalen Hurts Placed on Injured Reserve Following Blood Clot Diagnosis**

In a significant development for the Philadelphia Eagles, star quarterback Jalen Hurts has been placed on injured reserve following the discovery of a blood clot in his leg. This decision was made by the team on Saturday, October 17, after consultations with medical professionals revealed the need for immediate treatment.

The blood clot was identified after the Eagles’ recent game in London against the Jacksonville Jaguars. Reports from ESPN and NFL Network indicate that medical experts believe the condition is treatable; however, the timeline for Hurts’ return to the playing field remains uncertain and will ultimately depend on the recommendations from his medical team.

As it stands, the three-time Pro Bowl player is expected to miss a minimum of six weeks of competition. During this time, he will undergo treatment for the clot, which typically involves the administration of blood-thinning medications. These anticoagulants are critical for managing blood clots but also prohibit players from participating in games while undergoing such treatment.

The Eagles are bracing for a challenging few weeks without their quarterback. The upcoming matches include encounters with the Carolina Panthers, Dallas Cowboys, Washington Commanders, and New York Giants. In Hurts’ absence, backup quarterback Tanner McKee has been designated to start against the Panthers, while rookie Cole Payton has been elevated to the second-string position.

The Eagles first made the news public via a detailed statement on Thursday, October 15. The club explained the circumstances surrounding the diagnosis, mentioning that an ultrasound was conducted as a precautionary measure following their game day activities in London. This exploratory procedure led to the discovery of a superficial blood clot, necessitating the team’s decision to sit Hurts indefinitely.

Prior to the diagnosis, Hurts had played under the assumption that it was safe to do so, following advice from medical staff both at home and abroad. The Eagles’ medical team undertook a comprehensive review of the ultrasound results before allowing Hurts to participate in the match against the Jaguars. The team indicated that doctors emphasised the importance of mobility and activity to prevent exacerbation of the injury.

Following the Eagles’ narrow 19-17 defeat to the Jaguars, medical staff observed movement within the small clot located in Hurts’ calf. The team was clear in stating that the wellbeing of their players remains their top priority and that decisions relating to their health are made through rigorous medical evaluations.

This diagnosis comes at a crucial point in the season, creating both optimism and apprehensions for the Eagles’ fans. While the franchise is hopeful for Hurts’ recovery, they face the challenge of maintaining performance levels in his absence. The Eagles’ coaching staff and supporters will be watching closely as McKee steps into a starting role, spotlighting his ability to lead the team during this critical period.

As Hurts embarks on his recovery journey, the Eagles organisation stresses the importance of prioritising health over competition. With medical oversight and adherence to treatment protocols, there remains hope that he can return stronger, reinforcing the belief that adequate recovery is paramount in professional sports.